PRESS RELEASE published on 12/10/2024 at 02:30, 1 year 5 months ago Inside Information / Other news releases
BRIEF published on 10/15/2024 at 07:35, 1 year 6 months ago Conclusion du recrutement pour l'essai clinique de MaaT Pharma Essai Clinique MaaT Pharma MaaT013 Avis DSMB Traitement AGvH
BRIEF published on 10/15/2024 at 07:35, 1 year 6 months ago MaaT Pharma Clinical Trial Recruitment Concluded Clinical Trial MaaT Pharma MaaT013 DSMB Notice AGvH Treatment
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce la fin du recrutement de son essai de Phase 3 ARES pour MaaT013 dans le traitement de la maladie aiguë du greffon contre l'hôte. Premiers résultats attendus en janvier 2025 MaaT Pharma MaaT013 Phase 3 ARES Maladie Aiguë Greffon Contre L'hôte
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
PRESS RELEASE published on 09/20/2024 at 09:07, 1 year 7 months ago Rapport Financier Semestriel 2024
BRIEF published on 09/04/2024 at 07:35, 1 year 8 months ago MaaT Pharma annonce sa participation à des conférences investisseurs et médicales en septembre Investisseurs Conférence Médicale Thérapies MET Transplantation Cellulaire Cancers
BRIEF published on 09/04/2024 at 07:35, 1 year 8 months ago MaaT Pharma Announces Participation in Investor and Medical Conferences in September Investors Cancers Medical Conference MET Therapies Cell Transplantation
PRESS RELEASE published on 09/04/2024 at 07:30, 1 year 8 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce sa participation aux conférences investisseurs et médicales en septembre, avec des présentations lors du Congrès annuel de la Society of Hematologic Oncology à Houston et à d'autres événements internationaux Conférences Investisseurs Microbiote MaaT Pharma Cancers
BRIEF published on 05/15/2024 at 07:35, 1 year 11 months ago MaaT Pharma clôture avec succès une levée de fonds de 19,2 millions d'euros Investissement Biotechnologie Essais Cliniques Levée De Fonds MaaT Pharma
Published on 05/11/2026 at 14:30, 1 hour 3 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 1 hour 33 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 1 hour 33 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 14:00, 1 hour 33 minutes ago Colosseum Bankable Feasibility Study Confirms High Margin Gold Project
Published on 05/11/2026 at 14:00, 1 hour 33 minutes ago Ur-Energy Reminds Shareholders and Interested Parties of First Quarter Conference Call and Webcast
Published on 05/11/2026 at 15:07, 25 minutes ago Original-Research: GFT Technologies SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 15:05, 27 minutes ago Original-Research: Serviceware SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 14:35, 57 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.21 Million Tokens, and Total Crypto and Total Cash Holdings of $13.4 Billion
Published on 05/11/2026 at 14:26, 1 hour 6 minutes ago CEWE Divests Its Commercial Online-Print Business to Cimpress and Fully Focuses on Its Core Photofinishing Business
Published on 05/11/2026 at 14:23, 1 hour 9 minutes ago EQS-Adhoc: CEWE Stiftung & Co. KGaA: CEWE divests Commercial Online-Print and focuses on growth in its core Photofinishing business
Published on 05/11/2026 at 10:48, 4 hours 44 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 4 hours 44 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 6 hours 16 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
